Oncotarget

Research Papers:

Analysis of mutational and clinicopathologic characteristics of lung adenocarcinoma with clear cell component

Chang Gu _, Xufeng Pan, Rui Wang, Yuan Li, Xuxia Shen, Jianxin Shi and Haiquan Chen

PDF  |  HTML  |  How to cite  |  Order a Reprint

Oncotarget. 2016; 7:24596-24603. https://doi.org/10.18632/oncotarget.8258

Metrics: PDF 650 views  |   HTML 891 views  |   ?  


Abstract

Chang Gu1,*, Xufeng Pan1,*, Rui Wang1,*, Yuan Li2, Xuxia Shen2, Jianxin Shi1, Haiquan Chen1,3

1Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China

2Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China

3Department of Thoracic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China

*These authors have contributed equally to this work

Correspondence to:

Haiquan Chen, e-mail: hqchen1@yahoo.com

Jianxin Shi, e-mail: shijianxin_sch@126.com

Keywords: lung adenocarcinoma with clear cell component, lung adenocarcinoma, mutations, prognosis

Received: November 06, 2015    Accepted: March 07, 2016    Published: March 22, 2016

ABSTRACT

Introduction: Lung adenocarcinoma with clear cell component is extremely rare and the cases reported in literature remain scarce. The biological behaviors, clinicopathologic characteristics, mutational status and prognosis of lung adenocarcinoma with clear cell component are still uncertain.

Methods: Thirty-eight lung adenocarcinomas with clear cell component and 1659 lung adenocarcinomas were subjected to the study. All the corresponding clinicopathologic data, the distributions of relapse-free survival (RFS) and overall survival (OS), and the status of gene mutations were investigated.

Results: Of 1697 adenocarcinomas, 38 (2.2%) had clear cell component. Fifty percent of adenocarcinomas with clear cell component (11/22) harbored EGFR mutation, 41 percent (9/22) harbored KRAS mutation and 5 percent (1/22) harbored AKT1 mutation. Univariable analysis revealed that sex, age, tumor stage, tumor size, nodal stage and pathology were all significant predictors of RFS and OS while the tumor size and nodal stage were still significant predictors in multivariable analysis. There were significantly differences in RFS and OS for lung adenocarcinomas with clear cell component compared with those lung adenocarcinomas.

Conclusions: Lung adenocarcinoma with clear cell component is a rare, malignant tumor with poor prognosis and displays more frequent EGFR and KRAS mutations.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 8258